Skip to content
Search

Latest Stories

Challenging titles: Taking BMA's lead PDA raises concerns over the term 'pharmacy professionals'

Challenging titles: Taking BMA's lead PDA raises concerns over the term 'pharmacy professionals'
The PDA recognises the similarities between the unwelcome use by the government and others of the terms ‘medical professionals’ in medicine, and ‘pharmacy professionals’ in pharmacy

A judicial review claim launched by the British Medical Association (BMA) against the General Medical Council (GMC) has parallelly intensified Pharmacists' Defence Association's (PDA) scrutiny over the use of the term 'pharmacy professionals'.

PDA has criticised the evolving definition of 'pharmacy professionals,' and the potential risks to patient safety amidst regulatory ambiguity as part of "a far wider agenda."


Concerns stem from what the PDA perceives as a blurring of distinctions between pharmacists and pharmacy technicians as "attempted homogenisation"  by bodies like the General Pharmaceutical Council (GPhC), NHS, and Royal Pharmaceutical Society (RPS).

Raising similar issue as the BMA against the GMC over its use of 'medical professionals for  doctors and Medical Associate Professions (MAPs), Mark Koizol, Chairman of the PDA has said:

"What we are concerned about is a much more dangerous, planned, and strategic direction which impacts upon the safety of patients."

Distinguishing between the role of a pharmacy technician and a pharmacist, the PDA has said that:

"Pharmacy technicians have either completed an NVQ level 3 course or, in most cases were simply added to the GPhC register via a grandparenting route.

"Pharmacy technicians do not participate in a final registration assessment."

Whereas, pharmacists need to graduate "from a four-year university MPharm course followed by a year of supervised foundation training" to then pass a final registration assessment to qualify as a pharmacist.

"As a result, these two pharmacy roles have very different requirements for their underpinning knowledge, competence, and the final quality assurance process before registration," the statement said.

A recurring problem

In December 2023, the GPhC publicly apologised for erroneously referring to pharmacy technicians as 'pharmacists technician'.

This incident highlighted concerns over accurate professional titles and their impact on patient safety and public protection, an issue underscored by the Professional Standards Authority (PSA) on its website.

The PDA claims that they have already written to the GPhC and recently questioned the pharmacy minister, Dame Andrea Leadsom over safety concerns due to "the blurring of the lines between pharmacists and pharmacy technicians but has not received a satisfactory response."

Moreover, when questioned about the use of pharmacy technicians by the Health Select Committee in its Inquiry into Pharmacy, the pharmacy minister gave a defensive response and did not provide "any real assurances on patient safety."

The association has also criticised pharmacists who "continue to participate in this blurring of the lines between roles are doing nothing more than colluding in the demise of their own profession".

"Other professions have already started to challenge the government through the courts and soon the time may come for pharmacists to do the same.," said Koizol.

"The PDA will watch the two existing legal challenges about the use of the phrase ‘medical professionals’ closely to consider what aspects of those cases might be used to challenge the use of the term ‘pharmacy professionals.”

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less